ArticleClinical research in cardiology : official journal of the German Cardiac Society2026
Predictors of echocardiographic response in the Budapest-CRT upgrade trial.
Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
BACKGROUND AND
aimsUp to 30% of patients fail to respond after cardiac resynchronization therapy (CRT). While echocardiographic predictors of response are well described in de novo CRT, evidence in CRT upgrade populations remains limited. We investigated predictors of echocardiographic response in the BUDAPEST-CRT Upgrade trial cohort.
methodsIn this randomized trial, 360 patients with heart failure and reduced ejection fraction (HFrEF) with priorly implanted pacemaker or ICD, ≥ 20% right ventricular (RV) pacing burden, and wide-paced QRS (≥ 150 ms) were randomized to CRT-D upgrade (n = 215) or ICD upgrade (n = 145). Echocardiographic response was defined as ≥ 15% reduction in left ventricular end-systolic volume (LVESV) at 12 months.
resultsAmong 275 patients with paired echocardiographic data, 161 (59%) were responders. Responders had fewer HF hospitalizations (0.6% vs. 7.0%, p = 0.003), more often received mineralocorticoid receptor antagonists (71% vs. 59%, p = 0.038), and showed a higher baseline RV pacing burden (88.9% vs. 83.4%, p = 0.025) than non-responders. Independent predictors of echocardiographic response were randomization to CRT-D (OR 5.57, 95% CI 2.56-12.12, p < 0.0001), greater RV pacing burden (OR 1.02 per %, 95% CI 1.00-1.04, p = 0.024), non-ischemic cardiomyopathy (OR 2.50, 95% CI 1.15-5.26, p = 0.021), and a lateral LV lead position (OR 8.79, 95% CI 1.28-60.39, p = 0.027).
conclusionsIn patients with pacing-induced cardiomyopathy, CRT-D upgrade significantly improved echocardiographic outcomes. Non-ischemic etiology, higher RV pacing burden, and lateral LV lead positioning were associated with greater benefit. These results underscore the importance of tailored patient selection and lead placement strategies to optimize CRT-D upgrade outcomes.
Indexed as
Identifiers
42616112What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.